1. Home
  2. ENTA vs NOA Comparison

ENTA vs NOA Comparison

Compare ENTA & NOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$14.06

Market Cap

374.6M

Sector

Health Care

ML Signal

HOLD

NOA

North American Construction Group Ltd. (no par)

N/A

Current Price

$14.10

Market Cap

480.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
ENTA
NOA
Founded
1995
1953
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Meat/Poultry/Fish
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
374.6M
480.9M
IPO Year
2012
2006

Fundamental Metrics

Financial Performance
Metric
ENTA
NOA
Price
$14.06
$14.10
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$20.40
N/A
AVG Volume (30 Days)
110.5K
102.3K
Earning Date
05-11-2026
05-13-2026
Dividend Yield
N/A
2.37%
EPS Growth
29.93
N/A
EPS
N/A
N/A
Revenue
$102,814,000.00
N/A
Revenue This Year
$7.76
$14.77
Revenue Next Year
N/A
$5.43
P/E Ratio
N/A
$18.05
Revenue Growth
16.48
N/A
52 Week Low
$4.96
$12.07
52 Week High
$17.15
$18.24

Technical Indicators

Market Signals
Indicator
ENTA
NOA
Relative Strength Index (RSI) 57.22 48.00
Support Level $13.39 $13.22
Resistance Level $15.52 $14.49
Average True Range (ATR) 0.76 0.41
MACD 0.20 0.17
Stochastic Oscillator 74.84 62.72

Price Performance

Historical Comparison
ENTA
NOA

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

About NOA North American Construction Group Ltd. (no par)

North American Construction Group Ltd is Canada's heavy civil construction and mining contractor provider. The company has provided services to oil, natural gas, and resource companies. The Company provides a wide range of mining and heavy civil construction services to customer in the resource development and industrial construction sectors within Canada, the United States, and Australia. The Company's reportable segments are Heavy Equipment Canada, Heavy Equipment Australia, and Other. Heavy Equipment Canada and Heavy Equipment Australia include all of aspects of the mining and heavy civil construction services provided within those geographic areas. Other includes mine management contract work in the United States, its external maintenance and rebuild programs.

Share on Social Networks: